fashion -WSS

fashion

author：focus 2025-10-02 05:38:59 - browse：562

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter:

In December, Vertex Pharmaceuticalsannounced results from a mid-stage clinical trial showing its experimental, non-opioid drug reduced pain in people with diabetes who have chronic pain. This quarter, the company will read out results from Phase 3 studies of the same pain drug, called VX-548, in people with acute pain following surgery.

The next big test of Alnylam Pharmaceuticals’pipeline of RNA-interference medicines looms with the outcome of a Phase 3 study called HELIOS-B that is investigating vutrisiran as a treatment for ATTR-CM, a progressive disease that leads to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

WSS

Obamacare plans could cover weight loss drugs

Hospitals are piloting generative AI tools as regulators play catch

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

A virus, fished out of a lake, may have saved a man’s life

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Bristol 'take

Wikipedia

fashion

entertainment

Apple is now the first public company to be valued at $3 trillion

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Virginia high school admissions case could be legal follow

The future of health care in the House

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage enrollment hits roughly 33.4 million

DIEP, the 'gold standard' of breast reconstruction, is under threat

Senate panel eyes new effort on drug shortages

Walensky prepares to leave CDC — and Congress — behind

Physician executives need more than on

hotspot

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

WATCH: Why do our ears pop?

Analysis of telehealth claims data suggest service duplication

Abridge raises $150m as clinical notes automation market heats up

Abridge raises $150m as clinical notes automation market heats up

leisure time

knowledge

Wikipedia

hotspot